Vertex Pharmaceuticals Charts Growth Beyond Its CF Monopoly
Vertex Pharmaceuticals, known for its cystic fibrosis monopoly, is expanding into new markets like diabetes and pain management with a pipeline targeting millions of new patients.
#Vertex Pharmaceuticals#Biotechnology#Stock Market